Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking Using Riboflavin/Dextran or Riboflavin/Methylcellulose

NCT04897503 is registered in ClinicalTrials.gov with Cornea and Laser Eye Institute as lead sponsor.

NCT NCT04897503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04897503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking Using Riboflavin/Dextran or Riboflavin/Methylcellulose
Lead sponsor
Cornea and Laser Eye Institute
Phase
Phase 3
Overall status
Unknown status
Start date
April 16, 2021
Completion date
December 31, 2025
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia, keratoconus